Blog dedicated to the continuous education in Gynecology and Endocrinology

 

HPV AND CERVICAL CANCER

powered by WordPress Multibox Plugin v1.3.5

HPV vaccination
Borruto F.

powered by WordPress Multibox Plugin v1.3.5

Management of preinvasive lesions of the cervix
Dexeus S.

Post to Twitter Post to Facebook

HUMAN PAPILLOMAVIRUS AND VACCINATION: KNOWLEDGE, ATTITUDES, AND BEHAVIOURAL INTENTION IN ADOLESCENTS AND YOUNG WOMEN IN ITALY.

Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF.

Br J Cancer. 2008 Jul 22;99(2):225-9.

This study assesses knowledge, attitudes, and behavioural intention towards human papillomavirus (HPV) infection and vaccination in a random sample of 1348 adolescents and young women aged 14-24 years in Italy. more

Post to Twitter Post to Facebook

HPV TESTING AS AN ADJUNCT TO CYTOLOGY IN THE FOLLOW UP OF WOMEN TREATED FOR CERVICAL INTRAEPITHELIAL NEOPLASIA.

Kitchener H, Walker P, Nelson L, Hadwin R, Patnick J, Anthony G, Sargent A, Wood J, Moore C, Cruickshank M.

BJOG. 2008 May 22

Objective To evaluate human papillomavirus (HPV) testing in combination with cytology in the follow up of treated women. Design A prospective study. Setting Three UK centres: Manchester, Aberdeen and London. Population or sample Women treated for cervical intraepithelial neoplasia (CIN). more

Post to Twitter Post to Facebook

IMPACT OF A PROPHYLACTIC QUADRIVALENT HUMAN PAPILLOMAVIRUS (TYPES 6, 11, 16, 18) L1 VIRUS-LIKE PARTICLE VACCINE IN A SEXUALLY ACTIVE POPULATION OF NORTH AMERICAN WOMEN.

Am J Obstet Gynecol. 2008 Mar;198(3):261.e1-11
Barr E, Gause CK, Bautista OM, Railkar RA, Lupinacci LC, Insinga RP, Sings HL, Haupt RM.

OBJECTIVE: The purpose of this study was to inform policy regarding human papillomavirus (HPV) vaccination in North America. We measured the clinical impact of HPV-6/-11/-16/-18 vaccination in North American women. STUDY DESIGN: The study enrolled 21,954 women, the majority aged 16-25, across 5 studies of a quadrivalent HPV vaccine or its HPV-16 vaccine prototype. more

Post to Twitter Post to Facebook

ORAL CONTRACEPTIVES AND CLINICAL RECURRENCE OF HUMAN PAPILLOMAVIRUS LESIONS AND CERVICAL INTRAEPITHELIAL NEOPLASIA FOLLOWING TREATMENT.

Int J Gynaecol Obstet. 2008 Feb;100(2):175-8.
Frega A, Scardamaglia P, Piazze J, Cerekja A, Pacchiarotti A, Verrico M, Moscarini M.

OBJECTIVE: To evaluate the effect of oral contraceptive use on the recurrence rate of human papillomavirus (HPV) lesions and cervical intraepithelial neoplasia (CIN) following ablative or excisional procedures in a long-term follow-up. METHOD: The study was conducted with 650 oral contraceptive users presenting with HPV lesions and/or CIN, and 670 women who had these lesions but did not use oral contraceptives acted as controls. more

Post to Twitter Post to Facebook

© International Society of Gynecological Endocrinology - Privacy Policy